Shiqi Huang is a Ph.D. graduated from West China School of Pharmacy. Currently, She serves as a full-time associate researcher and works in the research professor Ling Zhang's group. She was supported by the National Science Fund for Young Scholars, National Fund for Postdoctoral Research Projects, No.75 General Fund of China Postdoctoral Science Foundation, and Science Fund for Young Scholars of Sichuan Province.

Drug delivery systems and targeted nanomaterials.

1．Shiqi Huang, Yining Zhu, Ling Zhang*, and Zhirong Zhang. Recent Advances in Delivery Systems for Genetic and Other Novel Vaccines. Advanced Materials, 2021: 2107946.

2．Shiqi Huang, Yicong Zhang, Luyao Wang, Wei Liu, Linyu Xiao, Qing Lin, Tao Gong, Xun Sun, Qin He, Zhirong Zhang, and Zhang Ling*. Improved Melanoma Suppression with Target-delivered TRAIL and Paclitaxel by a multifunctional Nanocarrier. Journal of Controlled Release, 2020,325:10-24.

3．Shiqi Huang, Lang Deng, Hanming Zhang, Luyao Wang, Yicong Zhang, Qing Lin, Tao Gong, Xun Sun, Zhirong Zhang*, and Ling Zhang*. Co-delivery of TRAIL and paclitaxel by fibronectin-targeting liposomal nanodisk for effective lung melanoma metastasis treatment. Nano Research, 2022, 15(1): 728-737.

4．Shiqi Huang, Hanming Zhang, Yicong Zhang, Luyao Wang, Zhirong Zhang, and Ling Zhang*. Comparison of two methods for tumour-targeting peptide modification of liposomes. Acta Pharmacologica Sinica, 2023, 44(4): 832-840.

5．Hanming Zhang, Honglin Gao, Yicong Zhang, Yikun Han, Qing Lin, Tao Gong, Xun Sun, Zhirong Zhang, Ling Zhang*, and Shiqi Huang*. Enzyme-activatable disk-shaped nanocarriers augment tumor permeability for breast cancer combination therapy. Nano Research, 2024: 1-11.

6. Jiaxi Han, Haozhou Shu, Ling Zhang*, and Shiqi Huang*. Latest advances in hydrogel therapy for ocular diseases. Polymer, 2024, 306: 127207.